Skip to main content
. 2022 Jul 6;2022:1817339. doi: 10.1155/2022/1817339

Figure 1.

Figure 1

TP53 mutational status in EC patients from TCGA dataset. (a) Kaplan–Meier (K-M) analysis confirmed that the patients with TP53 mutation have poor survival outcome. (b–e) TP53 mutation was related to poor outcome, older age, lower BMI, and higher levels of grade and stage of patients with EC.